These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21744112)

  • 1. Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease.
    Nobili F; Arnaldi D; Campus C; Ferrara M; De Carli F; Brugnolo A; Dessi B; Girtler N; Morbelli S; Abruzzese G; Sambuceti G; Rodriguez G
    Eur J Nucl Med Mol Imaging; 2011 Dec; 38(12):2209-18. PubMed ID: 21744112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study.
    Nobili F; Campus C; Arnaldi D; De Carli F; Cabassi G; Brugnolo A; Dessi B; Morbelli S; Sambuceti G; Abbruzzese G; Rodriguez G
    Mov Disord; 2010 Jan; 25(1):35-43. PubMed ID: 20058228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amnestic mild cognitive impairment in Parkinson's disease: a brain perfusion SPECT study.
    Nobili F; Abbruzzese G; Morbelli S; Marchese R; Girtler N; Dessi B; Brugnolo A; Canepa C; Drosos GC; Sambuceti G; Rodriguez G
    Mov Disord; 2009 Feb; 24(3):414-21. PubMed ID: 19235928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.
    Nobili F; Brugnolo A; Calvini P; Copello F; De Leo C; Girtler N; Morbelli S; Piccardo A; Vitali P; Rodriguez G
    Clin Neurophysiol; 2005 Feb; 116(2):364-75. PubMed ID: 15661114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What predicts cognitive decline in de novo Parkinson's disease?
    Arnaldi D; Campus C; Ferrara M; Famà F; Picco A; De Carli F; Accardo J; Brugnolo A; Sambuceti G; Morbelli S; Nobili F
    Neurobiol Aging; 2012 Jun; 33(6):1127.e11-20. PubMed ID: 22226489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPECT neuroimaging and neuropsychological functions in different stages of Parkinson's disease.
    Paschali A; Messinis L; Kargiotis O; Lakiotis V; Kefalopoulou Z; Constantoyannis C; Papathanasopoulos P; Vassilakos P
    Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1128-40. PubMed ID: 20145921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD).
    Nobili F; Morbelli S; Arnaldi D; Ferrara M; Campus C; Brugnolo A; Mazzei D; Mehrdad N; Sambuceti G; Rodriguez G
    J Neurol Sci; 2011 Nov; 310(1-2):31-5. PubMed ID: 21762928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders.
    Navalpotro-Gomez I; Dacosta-Aguayo R; Molinet-Dronda F; Martin-Bastida A; Botas-Peñin A; Jimenez-Urbieta H; Delgado-Alvarado M; Gago B; Quiroga-Varela A; Rodriguez-Oroz MC
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2065-2076. PubMed ID: 31273436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease.
    Siepel FJ; Brønnick KS; Booij J; Ravina BM; Lebedev AV; Pereira JB; Grüner R; Aarsland D
    Mov Disord; 2014 Dec; 29(14):1802-8. PubMed ID: 25284687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (99m)Tc-ethyl cysteinate dimer brain SPECT findings in early stage of dementia with Lewy bodies and Parkinson's disease patients: a correlation with neuropsychological tests.
    Chang CC; Liu JS; Chang YY; Chang WN; Chen SS; Lee CH
    Eur J Neurol; 2008 Jan; 15(1):61-5. PubMed ID: 18042240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nigrostriatal dopamine-independent resting-state functional networks in Parkinson's disease.
    Ham JH; Cha J; Lee JJ; Baek GM; Sunwoo MK; Hong JY; Shin NY; Sohn YH; Lee JM; Lee PH
    Neuroimage; 2015 Oct; 119():296-304. PubMed ID: 26143204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive functions in Parkinson's disease: relation to disease severity and hallucination.
    Wakamori T; Agari T; Yasuhara T; Kameda M; Kondo A; Shinko A; Sasada S; Sasaki T; Furuta T; Date I
    Parkinsonism Relat Disord; 2014 Apr; 20(4):415-20. PubMed ID: 24467818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
    Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease.
    Melzer TR; Watts R; MacAskill MR; Pearson JF; Rüeger S; Pitcher TL; Livingston L; Graham C; Keenan R; Shankaranarayanan A; Alsop DC; Dalrymple-Alford JC; Anderson TJ
    Brain; 2011 Mar; 134(Pt 3):845-55. PubMed ID: 21310726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study.
    Pellecchia MT; Picillo M; Santangelo G; Longo K; Moccia M; Erro R; Amboni M; Vitale C; Vicidomini C; Salvatore M; Barone P; Pappatà S
    Acta Neurol Scand; 2015 May; 131(5):275-81. PubMed ID: 25644029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substantia nigra echogenicity: A structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson's disease.
    Weise D; Lorenz R; Schliesser M; Schirbel A; Reiners K; Classen J
    Mov Disord; 2009 Aug; 24(11):1669-75. PubMed ID: 19514075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study.
    Nobili F; Frisoni GB; Portet F; Verhey F; Rodriguez G; Caroli A; Touchon J; Calvini P; Morbelli S; De Carli F; Guerra UP; Van de Pol LA; Visser PJ
    J Neurol; 2008 Sep; 255(9):1344-53. PubMed ID: 18958573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain perfusion alterations in depressed patients with Parkinson's disease.
    Kim YD; Jeong HS; Song IU; Chung YA; Namgung E; Kim YD
    Ann Nucl Med; 2016 Dec; 30(10):731-737. PubMed ID: 27566684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global cognitive impairment should be taken into account in SPECT-neuropsychology correlations: the example of verbal memory in very mild Alzheimer's disease.
    Rodriguez G; Morbelli S; Brugnolo A; Calvini P; Girtler N; Piccardo A; Dougall NJ; Ebmeier KP; Baron JC; Nobili F
    Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1186-92. PubMed ID: 15931515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.
    Ruppert MC; Greuel A; Tahmasian M; Schwartz F; Stürmer S; Maier F; Hammes J; Tittgemeyer M; Timmermann L; van Eimeren T; Drzezga A; Eggers C
    Brain; 2020 Mar; 143(3):944-959. PubMed ID: 32057084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.